Managing intraductal papillary mucinous neoplasms (IPMN) is complex, with surgical outcomes hinging on nuanced patient preferences.

• Clinicians and patients often interpret malignancy risks and surgical outcomes differently, leading to care inconsistencies.
• Implementing shared decision-making (SDM) frameworks can enhance risk communication and align treatment with patient values.

SDM may help reduce unnecessary surgeries and improve patient satisfaction by fostering clearer conversations about risks and choices.

• Emerging decision-support tools can further improve management by aligning clinical decisions with individual patient preferences.